fimasartan and its Impurities

Fimasartan is an angiotensin receptor antagonist drug. It is employed in the treatment of both hypertension and heart failure. Reference standards of Fimasartan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 8 results for fimasartan Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 33 10000

Fimasartan

Fimasartan


  • Catalogue No.:PA 33 10000

  • CAS :

    247257-48-3

  • Molecular Formula : C27H31N7OS

  • Molecular Weight : 501.65

Drug Reference Standards & Impurity Synthesis in India
PA 33 10510

2-(2-Butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide compound with 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide (1:1)

2-(2-Butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide compound with 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide (1:1)


  • Catalogue No.:PA 33 10510

  • CAS :

    NA

  • Molecular Formula : C56H66N14O2S2

  • Molecular Weight : 1031.35

Drug Reference Standards & Impurity Synthesis in India
PA 33 10520

2-(2-Butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide

2-(2-Butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide


  • Catalogue No.:PA 33 10520

  • CAS :

    1361024-52-3

  • Molecular Formula : C46H45N7OS

  • Molecular Weight : 743.97

Drug Reference Standards & Impurity Synthesis in India
PA 33 10530

5-Despyrimidineethanethioamide-5-pyrimidineacetamide Fimasartan Hydrochloride

5-Despyrimidineethanethioamide-5-pyrimidineacetamide Fimasartan Hydrochloride


  • Catalogue No.:PA 33 10530

  • CAS :

    NA

  • Molecular Formula : C27H32ClN7O2

  • Molecular Weight : 522.05

Drug Reference Standards & Impurity Synthesis in India
PA 33 10540

2-(2-Butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylacetamide

2-(2-Butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylacetamide


  • Catalogue No.:PA 33 10540

  • CAS :

    1315478-13-7

  • Molecular Formula : C13H21N3O2

  • Molecular Weight : 251.33

Drug Reference Standards & Impurity Synthesis in India
PA 33 0101000

2-(2-Butyl-1,4-dimethyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N-methylacetamide

2-(2-Butyl-1,4-dimethyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N-methylacetamide


  • Catalogue No.:PA 33 0101000

  • CAS :

    2514264-46-9

  • Molecular Formula : C13H21N3O2

  • Molecular Weight : 251.33

Drug Reference Standards & Impurity Synthesis in India
PA 33 0101001

5-Despyrimidineethanethioamide-5-pyrimidineacetamide Fimasartan

5-Despyrimidineethanethioamide-5-pyrimidineacetamide Fimasartan


  • Catalogue No.:PA 33 0101001

  • CAS :

    178554-19-3

  • Molecular Formula : C27H31N7O2

  • Molecular Weight : 485.59

Drug Reference Standards & Impurity Synthesis in India
PA 33 0101002

2-(2-Butyl-4-methyl-6-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-3-yl)methoxy)pyrimidin-5-yl)-N,N-dimethylacetamide

2-(2-Butyl-4-methyl-6-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-3-yl)methoxy)pyrimidin-5-yl)-N,N-dimethylacetamide


  • Catalogue No.:PA 33 0101002

  • CAS :

    NA

  • Molecular Formula : C46H45N7O2

  • Molecular Weight : 727.91

pharmaffiliates